Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib significantly improved hair regrowth and quality of life in severe alopecia areata patients.

Cosmerna ARI effectively reduces hair loss and increases hair density in Europeans with androgenetic alopecia.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

1′S-1′-Acetoxychavicol acetate may help treat hair loss by reducing oxidative stress.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

CS12192 effectively treats alopecia areata with better safety than current options.

Acorus calamus has potential health benefits but needs more safety research.

Ac-GFFY-IGF peptide is a promising, safe, and effective treatment for hair loss, better than current options.

Dicentrine reduced heart disease risk factors in rats, T-588 protected mice brains without side effects, Provir blocked herpes virus and lessened mouse symptoms, and LY191704 could treat hair loss and prostate issues.

Annurca apple extract improved hair growth in mice and could potentially prevent hair loss.

A botanical extract was found to be a safe treatment that may prevent hair loss in chemotherapy patients.

Two new IRAK4-inhibitors effectively reduced skin inflammation and immune response markers in healthy volunteers.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

A standard protocol for alopecia areata clinical trials was created to improve consistency and encourage more research.

Detachable microneedles with chitin derivatives effectively promote hair regrowth in androgenic alopecia without toxicity.

Semecarpus anacardium Linn. is a plant with many health benefits, including reducing inflammation, fighting cancer, and stimulating hair growth.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

DiluCap improves how quickly minoxidil and finasteride dissolve and controls the release of melatonin and naltrexone.

Baricitinib was effective in treating both early and late onset alopecia areata.

Upadacitinib can effectively regrow hair in alopecia areata patients without worsening sarcoidosis.

These migraine prevention drugs can cause side effects like constipation, hair loss, injection site reactions, fatigue, and sometimes unexpected issues like Raynaud's phenomenon and weight gain.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

PEA-ENL improves skin delivery and reduces inflammation without side effects.

Clascoterone may be an effective topical treatment for hair loss.

RADA16-I can effectively deliver and release mangiferin, improving its solubility and bioavailability.

Fludalanine failed as an effective oral antibiotic despite efforts.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.